Education
About Us
Working with TipRanks
Follow Us
ECML - ETF AI Analysis
Top Page
Euclidean Fundamental Value ETF (ECML)
Rating:70Outperform
Price Target:―
Positive Factors
Strong Top Holdings
Several of the largest positions, such as PTC Therapeutics and Oshkosh, have delivered strong year-to-date gains, supporting the fund’s overall performance.
Sector Diversification
The ETF is spread across multiple sectors, including Consumer Cyclical, Health Care, and Industrials, reducing reliance on any single industry.
Healthy Performance Trend
The fund has shown steady growth over the past three months, indicating positive momentum despite short-term fluctuations.
Negative Factors
High Expense Ratio
The ETF charges a relatively high expense ratio compared to many other funds, which can eat into investor returns over time.
Geographic Concentration
With nearly all assets focused in the U.S., the fund lacks meaningful exposure to international markets, limiting global diversification.
Short-Term Underperformance
The ETF experienced a decline in the past month, which may concern investors looking for consistent returns.
ECML vs. SPDR S&P 500 ETF (SPY)
AUM132.11M
RegionNorth America
Expense Ratio0.95%
Beta0.83
IssuerEuclidean
Inception DateMay 18, 2023
Dividend Yield0.92%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume63
30 Day Avg. Volume2,276
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
37.19Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering64
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ECML Summary
The Euclidean Fundamental Value ETF (ECML) is designed for investors who want to focus on value investing across the entire market. It includes companies that are financially strong and have growth potential but are trading at lower prices than their true worth. Some of its top holdings include well-known names like Fox and Altria Group. This ETF is a good option for those looking to diversify their portfolio and invest in undervalued companies with the potential for long-term growth. However, new investors should be aware that the ETF’s performance depends on the overall market and the success of the value investing strategy, which can sometimes underperform during periods of rapid market growth.
How much will it cost me?The Euclidean Fundamental Value ETF (ECML) has an expense ratio of 0.95%, meaning you’ll pay $9.50 per year for every $1,000 invested. This is higher than average because it is actively managed, requiring more research and analysis to select investments compared to passively managed ETFs that track an index.
What would affect this ETF?The Euclidean Fundamental Value ETF (ECML) could benefit from a strong U.S. economy, especially in sectors like Consumer Cyclical and Health Care, which make up a significant portion of its portfolio. However, rising interest rates or economic slowdowns might negatively impact consumer spending and corporate growth, particularly in cyclical industries. Regulatory changes or shifts in energy and materials markets could also influence performance, given the ETF's exposure to these sectors.
ECML Top 10 Holdings
The Euclidean Fundamental Value ETF (ECML) leans heavily into value-driven opportunities, with a notable focus on U.S.-based consumer cyclical and healthcare stocks. Pediatrix Medical Group and PTC Therapeutics are rising stars, delivering strong performance thanks to robust earnings and technical momentum. Meanwhile, Perdoceo Education is lagging, weighed down by bearish technical trends despite solid fundamentals. Newmont Mining adds a touch of sparkle with its bullish outlook, though potential overbought conditions warrant caution. Overall, the fund’s diverse sector exposure balances its tilt toward undervalued gems, making it a compelling choice for value-focused investors.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Dillard's | 2.84% | $4.14M | $10.90B | 57.21% | 76 Outperform | |
| Mueller Industries | 2.82% | $4.11M | $12.60B | 44.17% | 78 Outperform | |
| Heidrick & Struggles | 2.79% | $4.06M | $1.23B | 31.31% | 75 Outperform | |
| Fox | 2.69% | $3.91M | $28.60B | 45.53% | 77 Outperform | |
| Pediatrix Medical Group | 2.44% | $3.56M | $1.90B | 49.46% | 76 Outperform | |
| PTC Therapeutics | 2.40% | $3.49M | $6.20B | 60.81% | 73 Outperform | |
| Alcoa | 2.28% | $3.32M | $11.33B | 3.01% | 74 Outperform | |
| Newmont Mining | 2.24% | $3.27M | $97.95B | 118.34% | 81 Outperform | |
| Laureate Education | 2.15% | $3.13M | $4.57B | 67.96% | 73 Outperform | |
| Oshkosh | 2.12% | $3.09M | $8.19B | 21.38% | 71 Outperform |
ECML Technical Analysis
Positive
―
Price Trends
32.90
Positive
32.72
Positive
31.50
Positive
Market Momentum
0.30
Negative
63.91
Neutral
94.11
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ECML, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 32.93, equal to the 50-day MA of 32.90, and equal to the 200-day MA of 31.50, indicating a bullish trend. The MACD of 0.30 indicates Negative momentum. The RSI at 63.91 is Neutral, neither overbought nor oversold. The STOCH value of 94.11 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ECML.
ECML Peer Comparison
Comparison Results
Performance Comparison
ECML
Euclidean Fundamental Value ETF
33.82
-0.50
-1.46%
VFVA
Vanguard U.S. Value Factor ETF
―
―
―
LSVD
LSV Disciplined Value ETF
―
―
―
QVAL
Alpha Architect U.S. Quantitative Value ETF
―
―
―
AIVL
WisdomTree U.S. AI Enhanced Value Fund
―
―
―
BUSA
Brandes U.S. Value ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents